amoxapine has been researched along with Neurotic Disorders in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
Excerpt | Relevance | Reference |
---|---|---|
"During a four-week open study, amoxapine (AX), a new antidepressant agent, was administered to seven patients with pseudoneurotic schizophrenia, seven with neurosis and another seven with schizophrenia, all having similar symptoms." | 9.05 | Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia. ( Aono, T; Kaneko, M; Kumashiro, H; Numata, Y; Takahashi, Y; Yamamoto, T, 1981) |
"During a four-week open study, amoxapine (AX), a new antidepressant agent, was administered to seven patients with pseudoneurotic schizophrenia, seven with neurosis and another seven with schizophrenia, all having similar symptoms." | 5.05 | Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia. ( Aono, T; Kaneko, M; Kumashiro, H; Numata, Y; Takahashi, Y; Yamamoto, T, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aono, T | 1 |
Kaneko, M | 1 |
Numata, Y | 1 |
Takahashi, Y | 1 |
Yamamoto, T | 1 |
Kumashiro, H | 1 |
1 trial available for amoxapine and Neurotic Disorders
Article | Year |
---|---|
Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia.
Topics: Adult; Amoxapine; Clinical Trials as Topic; Dibenzoxazepines; Female; Humans; Male; Neurotic Disorde | 1981 |